• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The possible mode of action of indapamide: a review.

作者信息

Campbell D B

出版信息

Curr Med Res Opin. 1983;8 Suppl 3:9-24. doi: 10.1185/03007998309109832.

DOI:10.1185/03007998309109832
PMID:6352188
Abstract

It is not clear whether indapamide reduces blood pressure by a vasodilator or a diuretic action. This review attempts to answer this fundamental question. Cardiovascular studies show small increases in cardiac output, heart rate and stroke volume with a significant reduction in peripheral resistance. Indapamide, in vitro, directly inhibits pressor stimuli probably through a reduction of calcium flux in vascular smooth muscle, whilst diuretics are inactive. In vivo studies in man also show a reduction in sensitivity to pressor doses of noradrenaline and angiotensin without an increase in adrenergic sensitivity. However, indapamide does have mild diuretic activity at therapeutic doses, as shown by changes in plasma sodium, potassium, urea, uric acid and a reduction in body weight, but the changes are appreciably less than with thiazides. These results would suggest that indapamide has both diuretic and vasodilator properties. A low urinary excretion and specific accumulation into arterial smooth muscle of this lipophilic molecule may provide a rationale for this dual activity.

摘要

相似文献

1
The possible mode of action of indapamide: a review.
Curr Med Res Opin. 1983;8 Suppl 3:9-24. doi: 10.1185/03007998309109832.
2
Diuretic and cardiovascular effects of indapamide in hypertensive subjects: a dose-response curve.
Curr Med Res Opin. 1983;8 Suppl 3:47-52. doi: 10.1185/03007998309109835.
3
Extrarenal contributions to indapamide's antihypertensive mechanism of action.
Am Heart J. 1983 Jul;106(1 Pt 2):221-9. doi: 10.1016/0002-8703(83)90120-5.
4
Comparison of indapamide with thiazide diuretics in patients with essential hypertension.吲达帕胺与噻嗪类利尿剂治疗原发性高血压患者的比较。
Med J Aust. 1981 Jul 25;2(2):100-1. doi: 10.5694/j.1326-5377.1981.tb100812.x.
5
Preclinical studies of indapamide, a new 2-methylindoline antihypertensive diuretic.
Am Heart J. 1983 Jul;106(1 Pt 2):208-11. doi: 10.1016/0002-8703(83)90118-7.
6
[Antihypertensive action of indapamide in hypertension of chronic renal failure].吲达帕胺对慢性肾衰竭高血压的降压作用
Ann Cardiol Angeiol (Paris). 1994 Jan;43(1):43-8.
7
Correction of altered noradrenaline reactivity in essential hypertension by indapamide.吲达帕胺对原发性高血压中去甲肾上腺素反应性改变的纠正作用。
Br Heart J. 1981 Oct;46(4):404-9. doi: 10.1136/hrt.46.4.404.
8
Effect of indapamide on volume-dependent hypertension, renal haemodynamics, solute excretion and proximal nephron fractional reabsorption in the dog.吲达帕胺对犬容量依赖性高血压、肾血流动力学、溶质排泄及近端肾单位分数重吸收的影响。
Curr Med Res Opin. 1983;8 Suppl 3:25-37. doi: 10.1185/03007998309109833.
9
Metabolic effects on indapamide.吲达帕胺的代谢作用。
N Z Med J. 1990 Jan 24;103(882):20.
10
Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.吲达帕胺。其药效学特性及治疗高血压疗效的综述。
Drugs. 1984 Sep;28(3):189-235. doi: 10.2165/00003495-198428030-00001.

引用本文的文献

1
The Efficacy and Tolerability of a Fixed Combination of Perindopril and Indapamide in the Treatment of Unregulated Essential Hypertension - a Postmarketing Study.培哚普利/吲达帕胺复方制剂治疗未控制的原发性高血压的疗效和耐受性 - 一项上市后研究。
Acta Med Acad. 2022 Dec;51(3):163-174. doi: 10.5644/ama2006-124.385. Epub 2022 Dec 15.
2
Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.吲达帕胺。其药效学特性及治疗高血压疗效的综述。
Drugs. 1984 Sep;28(3):189-235. doi: 10.2165/00003495-198428030-00001.
3
Diuretics. Clinical pharmacology and therapeutic use (Part II).
利尿剂。临床药理学与治疗应用(第二部分)。
Drugs. 1985 Feb;29(2):162-88. doi: 10.2165/00003495-198529020-00003.